Levofloxacin plus clot-removal for acute ischemic stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether adding the antibiotic levofloxacin to standard emergency clot-removal (endovascular thrombectomy) is safer and more effective for people with an acute ischemic stroke. It may help by reducing complications after the procedure, but it’s being studied to confirm benefits and risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- Your stroke is confirmed as an ischemic stroke and you received thrombectomy within 24 hours of symptom start
- Your stroke clot is in the front part of the brain (certain major artery blockages), confirmed by CTA or DSA
- Before this stroke, you were functioning independently or near-independently (mRS 1 or less)
- You can give informed consent (or your legal representative can)
- You likely can’t join if you have conditions that strongly increase risks from the procedure or levofloxacin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding the antibiotic levofloxacin to standard IV clot-busting treatment is safe and improves outcomes after an acute ischemic stroke. It may help by reducing complications related to infection or inflammation, but you must meet specific heart, liver, kidney, and medication-safety rules.
This trial tests whether the antibiotic levofloxacin can be given soon after an acute ischemic stroke to improve outcomes and monitor side effects. It’s for people with a moderate stroke severity who are not having certain emergency treatments or infections.
This trial tests adding the anti-clotting drug tirofiban to standard clot removal for people who have a stroke due to a narrowed artery in the brain. The goal is to see if this combination improves outcomes without raising bleeding risk.
This trial tests whether adding a medication called sivelestat sodium to emergency clot removal surgery (mechanical thrombectomy) can improve outcomes in patients with a specific type of stroke caused by a large blood clot in the front part of the brain. The goal is to see if this combination treatment leads to better recovery.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
This study tests whether adding a drug called human urinary kallidinogenase to standard clot-removal therapy helps people recover better after a large-vessel stroke. If you qualify, you would receive the drug or a placebo by IV along with the procedure, and doctors will monitor your recovery.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.